Omega-3 and 6 fatty acids balance in inflammatory response in patients with cancer and cachexia;Balanço entre ácidos graxos ômega-3 e 6 na resposta inflamatória em pacientes com câncer e caquexia

Revista de Nutricao

Volumn 19, Issue 5, 2006, Pages 611-621

  Garófolo, Adriana ^a   Petrilli, Antônio Sérgio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cachexia; Fatty acids; Inflammation; Malnutrition; Neoplasms

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ARTICLE; CACHEXIA; CANCER; CANCER PATIENT; CATABOLISM; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; HUMAN; INFLAMMATION; MALNUTRITION; PROGNOSIS; PROTEIN DEGRADATION; QUALITY OF LIFE;

EID: 33846274194     PISSN: 14155273     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1415-52732006000500009     Document Type: Article

References (51)

1. Wong PW, Enriquez A, Barrera R. Nutritional support in critically ill patients with cancer. Crit Care Clin. 2001; 17(3)
2. Harrison LE, Brennan MF. The role of total parenteral nutrition in the patient with cancer. Curr Prob Surg. 1995; 32(10):833-924.
3. Garófolo A. Estado nutricional de crianças e adolescentes com câncer [dissertação]. São Paulo: Escola Paulista de Medicina, Universidade Federal de São Paulo; 2000.
4. Holcomb GW, Ziegler MM. Nutrition and cancer in children. Surg Ann. 1990; 129-41.
5. Mauer AM, et al. Special nutrition needs of children with malignancies: a review. JPEN. 1990; 14:315-24.
6. Laviano A, Meguid MM, Yang ZJ, Gleason JR, Cangiano C, Fanelli FR. Cracking the riddle of cancer anorexia. Nutrition. 1996; 12:706-10.
7. Keefe DMK, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage E. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci. 1997; 92:385-9.
8. Tisdale MJ. Cancer caquexia: metabolic alterations and clinical manifestations. Nutrition. 1997; 13:1-7.
9. Kyle UG, Pirlich M, Schuetz T, Lochs H, Pichard C. Is nutritional depletion by nutritional risk index associated with increased length of hospital stay? A population-based study JPEN. 2004; 28(2):99-104.
10. Windsor JA, Graham LH. Weight loss with physiologic impairment. A basic indicator of surgical risk. Ann Surg. 1987; 207(3):290-6.
11. Villa ML, Ferrario E, Bergamasco E, Bozzetti F, Cozzaglio L, Clerici E. Reduced natural killer cell activity and IL-2 production in malnourished cancer patients. Br J Cancer. 1991; 63:1010-4.
12. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. A randomized control trial. Cancer. 1998; 82(2):395-401.
13. Garófolo A, Lopez FA. Novos conceitos e propostas na assistência nutricional da criança com câncer. Rev Paul Pediatr. 2002; 20:140-6.
14. Torosian MH. Cancer cachexia and nutrition support in the cancer patient. A clinical review. Cancerología. 1993; 39:1768-74.
15. Tchekmedyian SN, Halpert C, Ashley J, Herber D. Nutrition in advanced cancer: anorexia as a outcome variable and target of therapy. JPEN. 1992; 16(6):88S-92S.
16. Tisdale MJ. Cancer anorexia and cachexia. Nutrition. 2001; 17:438-42.
17. Cohen J, Lefor AT. Nutrition support and cancer. Nutrition. 2001; 17:698-9.
18. Slaviero KA, Clarke SJ, Rivory LP. Inflammatory response: an unrecognized source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol. 2003; 4(4):224-32.
19. Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz J Med Biol Res. 2003; 36(4):433.
20. Bistrian BR. Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads lecture. JPEN. 2003; 27(3):168.
21. Thompson WA, Lowry SF. Effect of nutrition on inflammatory mediators. In: Zaloga GP. Nutrition in critical care. St Louis: Mosby; 1994. p.505-23.
22. Agency for Healthcare Research and Quality. Effects of omega-3 fatty acids on organ transplantation. Department of Health and Human Services; 2005. p.115.
23. Fürst P. The striking diet of the island of Crete: lipid nutrition from the palaeolithic to the affluent modern society. Clin Nutr. 2002; 21(S2):9-14.
24. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000; 71(S):343-8.
25. Kelley DS. Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition. 2001; 17:669-73.
26. Grimble R. Use of n-3 fatty acid-containing lipid emulsions in the Intensive Care Unit environment: the scientist's view. Clin Nutr. 2002; 21(S2):15-21.
27. Robert O. Practical applications of fish oil (w-3 fatty acids) in primary care. J Am Board Pract. 2005; 18:28-36.
28. Institute of Medicine. Dietary Reference Intakes (DRIs) for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Part 1. Washington (DC): National Academy Press; 2002.
29. Nutrition and Health Collection. Danone Research Center. Nutritional recommendations. Lipids from alpha to omega. Paris: John Libbey Eurotext; 1999.
30. Lasztity N, Hamvas J, Biro L, et al. Effect of enterally administrad n-3 polynsaturated fatty acids in acute pancreatitis-a prospective radomized clinical trial. Clin Nutr. 2005; 24:198-205.
31. Meier R. Enteral fish oil in acute pancreatitis. Clin Nutr. 2005; 24:169-71.
32. Barber MD. Cancer caquexia and its treatment with fish-oil-enriched nutritional supplementation. Nutrition. 2001; 17:751-5.
33. Fearon KCH. The anticancer and anticachetic effects of n-3 fatty acids. Clin Nutr. 2002; 21(S2):73-7.
34. Hardmam WE. Omega-3 fatty acid to augment cancer therapy. J Nutr. 2002; 132:3508S-12S.
35. Barber MD, Ross JA, Preston T, Shenkin A, Fearon KCH. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr. 1999; 129:1120-5.
36. Barber MD, McMillan DC, Preston T, Ross JA, Fearon CH. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci. 2000; 98:389-99.
37. Park Y, Harris WS. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearence. J Lipid Res. 2003; 44(3):455-63.
38. Swails WS, Kenler AS, Driscoll DF, et al. Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery. JPEN. 1997; 21(5):266-74.
39. Mayer K, Gokorsch S, Fegbeutel C, et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med. 2003; 167(10):1321-8.
40. Tsekos E, Reuter C, Stehle P, Boeden G. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major adbominal surgery. Clin Nutr. 2004; 23(3):325-30.
41. Tsekos E, Reuter C, Stehle P, Boeden G. Corrigendum to "Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major adbominal surgery". Clin Nutr. 2004; 23(4):755-6.
42. Maclean CH, Newberry SJ, Mojica WA, et al. Effects of Omega-3 fatty acids on cancer. Evid Rep Technol Assess. 2005; 113(summ):1-4.
43. Grimble RF, Howell WM, O'Reilly, et al. The ability of fish oil to suppress tumor necrosis factor a production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor a production. Am J Clin Nutr. 2002; 76(2):454-9.
44. Hughes DA, Pinder AC, Piper Z, Johnson IT, Lund EK. Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr. 1996; 63(2):267-72.
45. Beck AS, Smith KL, Tisdale MJ. Anticachetic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res. 1991; 51(15):6089-93.
46. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged>55 y. Am J Clin Nutr. 2001; 73(3):539-48.
47. Wu D, Meydani SN. N-3 polyunsaturated fatty acids and immune function. Proc Nutr Soc. 1998; 57(4):503-9.
48. Institute of Medicine. Dietary reference intakes (DRIs) for vitamin C, vitamin E, selenium, and carotenoids. Washington (DC): National Academy Press; 2000.
49. Bloch AS, Shils ME. Appendix. In: Shils ME, Olson JA, Shike M. Modern nutrition in health and disease. 8th ed. Malvern: Lea & Febiger; 1994. p.A100-4.
50. Grimminger F, Seeger W, Mayer K. Use of n-3 fatty acid-containing lipid emulsions in the intensive care unit environment: the clinician's view. Clin Nutr. 2002; 21(S2):23-9.
51. Pablo MA, Puertollano MA, Cienfuegos GA. Biological and clinical significance of lipids as modulators of immune system functions. Clin Diagn Lab Immunol. 2002; 9(5):945-50.